Table 3.

Clinical outcomes between study cohorts.

Outcomes	Thrombocytopenia N = 696	Non-thrombocytopenia N = 4,219	P-value
Primary outcomes
28-day mortality, n (%)	21 (3.0%)	50 (1.2%)	0.001
In-hospital mortality, n (%)	24 (3.4%)	61 (1.4%)	0.001
Secondary outcomes
Length of ICU stay, days	2.8 (1.3, 4.6)	2.2 (1.2, 3.9)	<0.001
Length of hospital stay, days	8.3 (6.2, 12.7)	7.6 (5.4, 11.0)	<0.001
Length of ventilation time, hours	12.0 (4.7, 21.7)	5.9 (3.5, 15.6)	<0.001
Length of vasopressor time, hours	14.2 (3.0, 38.4)	12.0 (1.3, 29.9)	<0.001
Pericardial and chest drainage, ml	1,062 (762, 1,648)	800 (535, 1,150)	<0.001
CRRT first day	11 (1.6%)	62 (1.5%)	0.738

Values are expressed as median (interquartile range), or n (%).

CRRT, continuous renal replacement therapy.

In bold are statistically significant values.